---
source_image: "legal-filing+deposition-transcript__EFTA01377759_20260130_p001_i001.png"
source_pdf: "EFTA01377759.pdf"
method: pdf_text
words: 649
confidence: 1.00
extracted: 2026-02-13T17:08:47.487033
---

S-1/A 
preferred stock at a purchase price of approximately $15.46345 per share, for an aggregate purchase price of $150.0 million. The 
following table summarizes purchases of our Series E convertible preferred stock by related persons: 
Shares of Series E 
Convertible 
Total Purchase 
Stockholder 
Preferred Stock 
Price 
Entities affiliated with Rizvi Traverse(1) 
485,014 
$ 
7,499,989.74 
JPMC Strategic Investments I Corporation(2) 
646.686 
$ 
9,999,996.63 
(1) 
Affiliates of Rizvi Traverse holding our securities whose shares are aggregated for purposes of reporting share ownership 
information are RT Spartan IV, LLC, RT SQ Co-Invest, LLC, RT SQ Secondary, LLC, RT-SQ TS, LLC, Rizvi 
168 
Table of Contents 
Opportunistic Equity Fund II, L.P., RT SQ Co-Invest II, LLC. Rizvi Opportunistic Equity Fund I-B. L.P., Rizvi Opportunistic 
Equity Fund, L.P., Rizvi Opportunistic Equity Fund I-B (TI), L.P., Rizvi Traverse Partners. LLC. Rizvi Traverse Partners II. 
LLC, and Rizvi Opportunistic Equity Fund (TI), L.P. 
(2) 
JPMC Strategic Investments I Corporation's ultimate parent is J.P. Morgan Chase & Co.. the ultimate parent of one of the 
underwriters of this offering. 
In addition, in October 2015. we sold an aggregate of 1.940.058 shares of our Series E convertible preferred stock at a 
purchase price of approximately $15.46345 per share, for an aggregate purchase price of $30.0 million, to one existing investor and 
one new investor. The investors who purchased shares of our Series E convertible preferred stock in October 2015 waived any 
right with respect to these shares to receive additional shares of our capital stock as a result of any conversion price adjustment 
arising from this offering. 
2014 Third-Party Tender Offer 
In January 2014. we entered into a letter agreement with certain holders of our capital stock, including entities affiliated with 
Rizvi Traverse, pursuant to which we agreed to waive certain transfer restrictions in connection with, and assist in the 
administration of, a tender offer that such holders proposed to commence. In January 2014. these holders commenced a tender 
offer to purchase shares of our capital stock from certain of our securityhoklers, including James McKelvey. Lawrence Summers, 
and Dana Wagner. An aggregate of 6,124,470 shares of our capital stock were tendered pursuant to the tender offer at a price of 
approximately $13.53 per share. 
Investors' Rights Agreement 
We are party to an amended and restated investors' rights agreement with certain holders of our capital stock, including Jack 
Dorsey, Jim McKelvey. Khosla Ventures III, LP, entities affiliated with JPMC Strategic Investments, entities affiliated with Sequoia 
Capital, entities affiliated with Rizvi Traverse, and an entity affiliated with Mary Meeker. Under our amended and restated investors' 
rights agreement, certain holders of our capital stock have the right to demand that we file a registration statement or request that 
their shares of our capital stock be covered by a registration statement that we are otherwise filing. See the section titled 
"Description of Capital Stockâ€”Registration Rights" for additional information regarding these registration rights. 
Right of First Refusal and Co-Sale Agreement 
Pursuant to our equity compensation plans and certain agreements with certain holders of our capital stock, including Jack 
Dorsey, Jim McKelvey, Khosla Ventures III, LP, entities affiliated with JPMC Strategic Investments, entities affiliated with Sequoia 
Capital, entities affiliated with Rizvi Traverse, and an entity affiliated with Mary Meeker, including an amended and restated right of 
first refusal and co-sale agreement, we or our assignees have a right to purchase shares of our capital stock which stockholders 
propose to sell to other parties. This right will terminate upon the completion of this offering. Since January 1, 2012. we have 
waived our right of first refusal in connection with the sale of certain shares of our capital stock, resulting in the purchase of such 
shares by certain of our stockholders. See the section titled "Principal and Selling Stockholders" for additional information regarding 
beneficial ownership of our capital stock. 
169 
http://vAnc..us:.gov/Archivestedgar/data/1512673AX$1119312515369092/d937622dsla.htm111/6/2015 7:37:12 AM( 
CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0074911 
SDNY_GM_00221095 
EFTA01377759
